22.10.2011
Generics in the United Kingdom - Performance of the Market Is Forecast To Decelerate, With an Anticipated CAGR Of 7.9% for the Five-Year Period 2010... [reading]

22.10.2011
The US Generics Market Had Total Revenue of $71.4 Billion in 2010, Representing A CAGR Of 8.2% between 2006 and 2010 [reading]

21.10.2011
Antares Pharma Granted New U.S. Patent Covering VIBEX? Injector Technology [reading]

21.10.2011
Drugs giants probed by EU anti-trust authority [Deutsche Welle] [reading]

20.10.2011
CMS` Transparency Push Could Revolutionize Drug Pricing [reading]

19.10.2011
Perrigo confirms filing for generic version of PATANASE nasal spray [reading]

19.10.2011
Pharmacists to Federal Medicaid Officials: Revamp Proposed Generic Drug Federal Upper Limits to Preserve Pharmacy Access for Patients [reading]

19.10.2011
Teva Pharmaceutical Industries Ltd. and Cephalon, Inc.; Analysis of Agreement Containing Consent Orders To Aid Public Comment [reading]

18.10.2011
Perrigo applies to FDA for generic nasal spray [reading]

18.10.2011
Watson confirms filing ANDA for generic version of Warner`s Atelvia [reading]

18.10.2011
Watson confirms filing ANDA with FDA for generic version of Noven`s Daytrana [reading]

17.10.2011
New NCPA Ads Feature Community Pharmacy Proposals to Reduce the Federal Deficit [reading]

Generic drugs news

Drugs giants probed by EU anti-trust authority [Deutsche Welle]

The EU Commission suspects the US-pharmaceuticals company Johnson & Johnson and the Swiss-based Novartis of having entered a deal to hamper the introduction of a generic painkiller into the market.The EU Commission accuses Johnson & Johnson of having paid Novartis for delaying the market entry of its generic painkiller Fentanyl in the Netherlands.

Fentanyl is used as an intravenous drug in anasthesia and as a transdermal patch in chronic pain treatment. Fentanyl is approximately 100 times more potent than morphine.

The EU body now wants to find out whether contractual agreements between Johnson & Johnson and Novartis may have had the "object or effect of hindering the entry" of the generic drug onto the Dutch market.

"Paying a competitor to stay out of the market is a restriction of competition that the commission will not tolerate," EU Competition Commissioner Joaquin Almunia said in a statement.

No proof of wrong-doing

At the same time, Almunia stressed that the opening of proceedings did not constitute proof of any violation of EU antitrust legislation. It did mean, however, that "the Commission will deal with the case as a matter of priority," Almunia said.

But there is no stated time period in which the Commission will come to a decision.

Should the Commission`s suspicion be confirmed, both companies could face a fine of up to 10 percent of their revenue. EU competition legislation bans practices that restrict competition, like price-fixing agreements and agreements to share markets.

Stefan Gijssels, spokesperson for Janssen Pharmaceutica, the Johnson & Johnson subsidiary involved, told Deutsche Welle he could not provide further information, but did confirm that the investigation focused on contractual agreements with Novartis subsidiaries Hexal and Sandoz concerning fentanyl patches in the Netherlands between 2005 and 2006.

Inquiry found shortcomings

In 2009, then EU Competition Commissioner Neelie Kroes had pledged to intensify scrutiny of the pharmaceutical sector, including monitoring of settlements between originator and generic drug companies.

An inquiry into the pharmaceutical sector in 2008 and 2009 had found that citizens waited more than seven months after patent expiry for cheaper generic medicines to be introduced. The inquiry also showed that the companies originally producing a given drug used a variety of instruments to delay generic entry for as long as possible in order to to extend the commercial life of their products.

The European Federation of Pharmaceutical Industries and Associations refuted these findings in a report, arguing that in introducing generics into the market there were "regulatory and commercial challenges involved" and that patent holding drug companies were not deliberately delaying market entry of generics.

Author: Andrea RnsbergEditor: Ben Knight

Viagra - is a world-known medication used to help men overcome erectile dysfunction (ED). Viagra is sold under various trade names like Sildenafil citrate, Revation and others depending on the country it is distributed in. Viagra is also prescribed for the treatment of pulmonary arterial hypertension.
25mg, 50mg, 100mg tablets
[ordering Sildenafil]

Cialis - do you suffer from ED and want to get an effective treatment for it? Tadalafil citrate is a medication specifically formulated to treat impotence in men. Moreover, it is known for its long-lasting effect, what gives an opportunity to have fruitful sexual experience at any time convenient to you and your partner.
5 mg, 10 mg, 40 mg pills
[ordering Tadalafil]

Levitra - also known as Vardenafil, is an erectile dysfunction medication. It works by relaxing penis blood vessels and letting the blood flow easily, thus it helps to maintain erection.
Dosages: 10mg, 20mg
[ordering Vardenafil]

VPXL - is a real godsend for men with small penis. VPXL is a herbal medication used to increase penis size. [ordering VPXL]

Propecia - is a drug prescribed to men suffering from intense hair loss.
Dosages: 1 mg, 5mg
[ordering Propecia]

Xenical - is prescribed as a dietary supplement to people suffering from corpulence. For better results it is recommended to use Xenical alongside low calorie diet and exercises. Xenical works by blocking the fat in the blood and help to reduce fat intake.
Doses: 60 mg, 120 mg
[ordering Xenical]

Acomplia - are you tired of excess weight? Are you afraid of other more serious medical conditions that can be caused by obesity? Acomplia was specifically formulated to help you avoid these problems. Acomplia is an effective remedy used for the treatment of corpulence.
Weght: 20 mg
[ordering Acomplia]

Tamiflu - is an antiviral drug used for the treatment of flu symptoms in patients suffering from influenza. Tamiflu is known for its fast relieving effect upon the virus.
Dose: 75 mg
[ordering Tamiflu]

What's the difference between generic drugs and brand-name drugs?
Actually, they both differ only in price and name, all the rest is the same. Generic drugs, as well as brand-name medications, have the same dosage, effects, including side effects, risks, strength and safety. They are like true copies of brand-name medications.

What makes generic drugs cheaper?
As a rule, in order to release and patent a certain drug the manufacturer should meet a range of requirements like developing, researching, marketing and promoting of a new medication. Overall, it is time- and money-consuming procedure, which leads to price growth. Speaking about generic drugs, they are usually brought unregistered onto the market, thus the manufacturer is exempt from paying taxes. However, the lower price here doesn't yield lower effectiveness. As a rule, the manufacturers of generic drugs are known reputable pharmaceutical companies.

What credit cards do you accept?
We accept Visa, MasterCard, AmEx, Diners and JCB cards.

Do you ship Internationally?
Yes, we ship Internationally at this time.

Order delay at customs: what to do?
It may happen that your order can be delayed at customs. In this case customs officers usually ask the recipient to come to the office and permit them to open a parcel in order to examine it. After this they give a parcel to the recipient. If you still have problems with getting your order, contact us so that we can help you solve this problem.